DarioHealth Corp. Income Statement
DRIO|5 years of annual SEC 10-K data (FY2014-FY2018)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$5M
FY2018
Gross Profit
$1M
25.4% gross margin
Operating Income
-$14M
FY2018
Net Income
-$16M
FY2018
DarioHealth Corp. reported $5M in revenue and $16M in net loss for FY2018. Revenue has grown at a 366.3% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Revenue | $5.2M | $2.8M | $823.0K | $51.0K | $0 |
| Cost of Revenue | $3.9M | $3.4M | $1.7M | $2.3M | $0 |
| Gross Profit | $1.3M | -$830.0K | -$855.0K | -$2.7M | $0 |
| SG&A Expense | $4.7M | $3.4M | $2.9M | $3.6M | $6.3M |
| R&D Expense | $3.3M | $2.2M | $2.6M | $3.9M | $4.9M |
| Operating Income | -$14.4M | -$11.1M | -$7.7M | -$11.4M | -$13.6M |
| Net Income | -$15.7M | -$10.9M | -$7.1M | -$12.9M | -$13.9M |
| EPS (Diluted) | $1.64 | $2.09 | $3.84 | $1.85 | $3.80 |
| Shares Outstanding | 14.1M | 5.7M | 2.9M | 16.2M | 4.0M |
| Gross Margin | 25.4% | -29.6% | -103.9% | -5317.6% | - |
| Operating Margin | -278.9% | -396.0% | -935.4% | -22270.6% | - |
| Profit Margin | -304.5% | -388.4% | -867.8% | -25249.0% | - |